Trial
NCT06247540
Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
National Cancer Institute (NCI); Bristol-Myers Squibb; AbbVie
Condition
Recurrent Transformed Chronic Lymphocytic Leukemia
Intervention
Biopsy
Why stopped
Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-29